(Q42858396)

8 November 2017

Short-term cellular effects induced by castration therapy in relation to clinical outcome in prostate cancer (English)

1 reference

8 November 2017

Stattin P

1

1 reference

8 November 2017

Westin P

series ordinal

2

1 reference

8 November 2017

Damber JE

series ordinal

3

1 reference

8 November 2017

Bergh A

series ordinal

4

1 reference

8 November 2017

language of work or name

English

0 references

publication date

1 February 1998

1 reference

British Journal of Cancer

8 November 2017

1 reference

8 November 2017

77

1 reference

8 November 2017

670-675

1 reference

8 November 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1998.107

8 November 2017

0 references

cites work

Down regulation of Bcl-2 is the first step on Fas-mediated apoptosis of male reproductive tract

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149918

Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149918

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149918

Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149918

Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149918

Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149918

Castration plus oestrogen treatment induces but castration alone suppresses epithelial cell apoptosis in an androgen-sensitive rat prostatic adenocarcinoma

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149918

The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149918

Serum PSA after antiandrogen therapy.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149918

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149918

Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149918

Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149918

Treatment of stage IV carcinoma of the prostate

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149918

Bcl-2 immunoreactivity in prostate tumorigenesis in relation to prostatic intraepithelial neoplasia, grade, hormonal status, metastatic growth and survival

27 May 2018

1 reference

12 December 2020

Therapy of prostatic cancer and histopathologic follow-up

1 reference

12 December 2020

Activation of programmed cell death in the rat ventral prostate after castration

1 reference

12 December 2020

Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation

1 reference

12 December 2020

Estrogen treatment combined with castration inhibits tumor growth more effectively than castration alone in the Dunning R3327 rat prostatic adenocarcinoma

1 reference

12 December 2020

Castration-induced changes in morphology, androgen levels, and proliferative activity of human prostate cancer tissue grown in athymic nude mice

1 reference

12 December 2020

Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness

1 reference

12 December 2020

Paradoxical inhibition of solid tumor cell growth by bcl2

1 reference

12 December 2020

Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma

1 reference

12 December 2020

Prostate specific antigen regression and progression after androgen deprivation for localized and metastatic prostate cancer

1 reference

12 December 2020

Cell proliferation and apoptosis during prostatic tumor xenograft involution and regrowth after castration

1 reference

12 December 2020

p53 immunoreactivity as prognostic marker for cancer-specific survival in prostate cancer

1 reference

12 December 2020

Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1998.107

1 reference

8 November 2017

1 reference

8 November 2017

1 reference